Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
LOC101930400 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
TRIM56 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NDUFA9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AKR1C1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NOD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AP1M1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PDLIM7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ADPRHL2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRR29 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TSHZ3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRR14L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BCL2L13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRIM69 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAX - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SPTA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NFE2L1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
N4BP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AKIRIN2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
S1PR2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on